Journal
WORLD JOURNAL OF STEM CELLS
Volume 15, Issue 5, Pages 400-420Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.4252/wjsc.v15.i5.400
Keywords
Key Words; Mesenchymal stromal/stem cells; Mesenchymal stromal/stem cell therapeutic properties; Mesenchymal stromal/stem cell paracrine effects; Mesenchymal stromal/stem cell priming; Pro-inflammatory priming; Hypoxic priming; 3D culture priming
Categories
Ask authors/readers for more resources
Mesenchymal stromal/stem cells (MSCs) have shown limited efficacy in treating human diseases due to their heterogeneity. Specific priming strategies have been used to improve the therapeutic properties of MSCs by directing their effects towards specific pathological processes. Fine-tuning the therapeutic properties of MSCs through different priming strategies could optimize their potential.
Mesenchymal stromal/stem cells (MSCs) have shown significant therapeutic potential, and have therefore been extensively investigated in preclinical studies of regenerative medicine. However, while MSCs have been shown to be safe as a cellular treatment, they have usually been therapeutically ineffective in human diseases. In fact, in many clinical trials it has been shown that MSCs have moderate or poor efficacy. This inefficacy appears to be ascribable primarily to the heterogeneity of MSCs. Recently, specific priming strategies have been used to improve the therapeutic properties of MSCs. In this review, we explore the literature on the principal priming approaches used to enhance the preclinical inefficacy of MSCs. We found that different priming strategies have been used to direct the therapeutic effects of MSCs toward specific pathological processes. Particularly, while hypoxic priming can be used primarily for the treatment of acute diseases, inflammatory cytokines can be used mainly to prime MSCs in order to treat chronic immune-related disorders. The shift in approach from regeneration to inflammation implies, in MSCs, a shift in the production of functional factors that stimulate regenerative or anti-inflammatory pathways. The opportunity to fine-tune the therapeutic properties of MSCs through different priming strategies could conceivably pave the way for optimizing their therapeutic potential.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available